Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002693
What this trial is testing

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia

Who this might be right for
LeukemiaNeutropenia
Mayo Clinic
Not applicableLooking for participantsNCT04986293
What this trial is testing

CPAP or BiPAP for Motion Mitigation During Radiotherapy

Who this might be right for
Radiotherapy Side EffectNSCLCEsophageal Cancer+1 more
University Medical Center Groningen 31
Large-scale testing (Phase 3)Study completedNCT00103506
What this trial is testing

Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 646
Early research (Phase 1)Study completedNCT01300247
What this trial is testing

Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON)

Who this might be right for
Lymphocytic Leukemia, Chronic
Genentech, Inc. 41
Testing effectiveness (Phase 2)UnknownNCT02047578
What this trial is testing

Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

Who this might be right for
Acute Lymphoblastic Leukemia
Seoul National University Hospital 38
Testing effectiveness (Phase 2)Study completedNCT00901147
What this trial is testing

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma (Not Otherwise Specified)Angioimmunoblastic T-cell LymphomaExtranodal NK/T-cell Lymphoma Nasal Type+4 more
Singapore General Hospital 25
Early research (Phase 1)Looking for participantsNCT06393738
What this trial is testing

ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Who this might be right for
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)
Arvinas Inc. 329
Testing effectiveness (Phase 2)Study completedNCT00004198
What this trial is testing

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Early research (Phase 1)Study completedNCT02780804
What this trial is testing

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Brain Stem NeoplasmPineal Region NeoplasmRecurrent Lymphoma+7 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT03349333
What this trial is testing

A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL

Who this might be right for
Refractory Peripheral T-Cell LymphomaRelapsed T-Cell Lymphoma
Mundipharma (China) Pharmaceutical Co. Ltd 85
Not applicableUnknownNCT04004338
What this trial is testing

Carfilzomib in Combination for the Treatment of RR MM

Who this might be right for
Multiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma
Black Sea Hematology Association 300
Testing effectiveness (Phase 2)Study completedNCT00280878
What this trial is testing

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma (CD20+)
Bayside Health 12
Not applicableUnknownNCT02345915
What this trial is testing

Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia

Who this might be right for
Leukemia, Myeloid, AcuteAcute Lymphoid Leukemia
Institut Paoli-Calmettes 90
Not applicableLooking for participantsNCT07013435
What this trial is testing

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Who this might be right for
Lymphoma
Massachusetts General Hospital 254
Not applicableStudy completedNCT00002563
What this trial is testing

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease

Who this might be right for
LymphomaPsychosocial Effects of Cancer and Its Treatment
SWOG Cancer Research Network 263
Testing effectiveness (Phase 2)Study completedNCT00971763
What this trial is testing

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
University College, London 62
Testing effectiveness (Phase 2)Ended earlyNCT00905398
What this trial is testing

Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemia
Rony Schaffel 8
Not applicableUnknownNCT06067321
What this trial is testing

Gastric Residual Volumes in Infants Fed at 4 and 6 Hours Prior to General Anaesthesia

Who this might be right for
FastingAnesthesiaPediatric ALL
King's College Hospital NHS Trust 70
Not applicableStudy completedNCT01615484
What this trial is testing

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Who this might be right for
EmphysemaChronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis+5 more
University of North Carolina, Chapel Hill 24
Large-scale testing (Phase 3)Looking for participantsNCT06522555
What this trial is testing

The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Ruijin Hospital 100
Next Page